JPWO2019175368A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019175368A5
JPWO2019175368A5 JP2020548991A JP2020548991A JPWO2019175368A5 JP WO2019175368 A5 JPWO2019175368 A5 JP WO2019175368A5 JP 2020548991 A JP2020548991 A JP 2020548991A JP 2020548991 A JP2020548991 A JP 2020548991A JP WO2019175368 A5 JPWO2019175368 A5 JP WO2019175368A5
Authority
JP
Japan
Prior art keywords
antigen
seq
amino acid
acid sequence
set forth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020548991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021515798A5 (https=
JP7288913B2 (ja
JP2021515798A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/056516 external-priority patent/WO2019175368A1/en
Publication of JP2021515798A publication Critical patent/JP2021515798A/ja
Publication of JPWO2019175368A5 publication Critical patent/JPWO2019175368A5/ja
Publication of JP2021515798A5 publication Critical patent/JP2021515798A5/ja
Application granted granted Critical
Publication of JP7288913B2 publication Critical patent/JP7288913B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020548991A 2018-03-14 2019-03-14 二重特異性egfr/cd16抗原結合タンパク質 Active JP7288913B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18161871 2018-03-14
EP18161871.1 2018-03-14
PCT/EP2019/056516 WO2019175368A1 (en) 2018-03-14 2019-03-14 Bispecific egfr/cd16 antigen-binding protein

Publications (4)

Publication Number Publication Date
JP2021515798A JP2021515798A (ja) 2021-06-24
JPWO2019175368A5 true JPWO2019175368A5 (https=) 2022-03-15
JP2021515798A5 JP2021515798A5 (https=) 2022-03-15
JP7288913B2 JP7288913B2 (ja) 2023-06-08

Family

ID=61683598

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020548991A Active JP7288913B2 (ja) 2018-03-14 2019-03-14 二重特異性egfr/cd16抗原結合タンパク質

Country Status (13)

Country Link
US (2) US11510972B2 (https=)
EP (1) EP3765157A1 (https=)
JP (1) JP7288913B2 (https=)
KR (1) KR102924742B1 (https=)
CN (1) CN111971090B (https=)
AU (1) AU2019235433B2 (https=)
BR (1) BR112020018492A2 (https=)
CA (1) CA3090464A1 (https=)
IL (1) IL276903B2 (https=)
MX (1) MX2020009445A (https=)
SG (1) SG11202007664WA (https=)
WO (1) WO2019175368A1 (https=)
ZA (1) ZA202006247B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL276903B2 (en) * 2018-03-14 2025-12-01 Affimed Gmbh Bispecific egfr/cd16 antigen-binding protein
KR20220119467A (ko) 2019-12-27 2022-08-29 아피메트 게엠베하 이중특이적 fcyriii x cd30 항체 작제물의 제조 방법
WO2023006082A1 (zh) * 2021-07-30 2023-02-02 启愈生物技术(上海)有限公司 抗原靶向、抗cd16a和免疫效应细胞激活三功能融合蛋白及其应用
CN116143942A (zh) * 2021-09-09 2023-05-23 启愈生物技术(上海)有限公司 抗原靶向、抗cd16a和免疫效应细胞激活三功能融合蛋白及其应用
JP2024543828A (ja) * 2021-11-03 2024-11-26 アフィメド ゲーエムベーハー 二重特異性cd16aバインダー
AU2022382368A1 (en) * 2021-11-03 2024-05-02 Affimed Gmbh Bispecific cd16a binders
WO2024186092A1 (ko) * 2023-03-06 2024-09-12 주식회사 드노보 바이오테라퓨틱스 신규한 항-cd16 항체 및 이의 용도
WO2024213097A1 (zh) * 2023-04-14 2024-10-17 山东先声生物制药有限公司 一种靶向人cd16和肿瘤抗原的多特异性抗体
WO2025167357A1 (zh) * 2024-02-06 2025-08-14 启愈生物技术(上海)有限公司 Cd80/taa融合蛋白相关的肿瘤靶向、t细胞激活分子形式及其应用
CN118221818B (zh) * 2024-04-29 2025-01-24 四川大学 一种抗cd16a的纳米抗体及其应用
WO2026017120A1 (zh) * 2024-07-18 2026-01-22 信达生物制药(苏州)有限公司 抗cdh17/egfr/cd16a三特异性抗体及其用途
CN118994409B (zh) * 2024-07-30 2025-07-22 郑州市乘黄生物医药科技有限公司 结合CD16A和Trop2的双特异性抗体-NK细胞偶联物及其用途
CN118791616A (zh) * 2024-09-14 2024-10-18 苏州为度生物技术有限公司天津分公司 一种抗人cd16工程抗体及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0510790D0 (en) 2005-05-26 2005-06-29 Syngenta Crop Protection Ag Anti-CD16 binding molecules
US8289183B1 (en) 2008-04-25 2012-10-16 Texas Instruments Incorporated System and method for solar panel array analysis
DK2560993T3 (da) 2010-04-20 2024-10-14 Genmab As Heterodimeric antibody fc-containing proteins and methods for production thereof
CN105153307A (zh) * 2010-05-04 2015-12-16 梅里麦克制药股份有限公司 抗表皮生长因子受体(egfr)的抗体及其用途
LT2794658T (lt) * 2011-12-19 2017-05-10 Synimmune Gmbh Bispecifinė antikūno molekulė
BR112015000167B1 (pt) 2012-07-06 2021-11-23 Genmab B.V. Proteína dimérica, proteína, composição, kit de partes e seus usos, bem como método para aumentar a oligomerização em solução de uma proteína dimérica compreendendo um primeiro e segundo polipeptídeo, cada um compreendendo pelo menos as regiões ch2 e ch3 de uma cadeia pesada de igg1 humana e proteína dimérica variante
AU2014227638A1 (en) 2013-03-15 2015-09-17 Merck Patent Gmbh Tetravalent bispecific antibodies
CN105555804B (zh) * 2013-08-07 2020-12-25 阿菲姆德股份有限公司 对EGFRvIII有特异性的抗体结合位点
TWI731535B (zh) * 2014-03-21 2021-06-21 美商艾伯維有限公司 抗-egfr抗體及抗體藥物結合物
EP2930188A1 (en) * 2014-04-13 2015-10-14 Affimed Therapeutics AG Trifunctional antigen-binding molecule
ES2754557T3 (es) * 2015-05-04 2020-04-20 Affimed Gmbh Combinación de un anticuerpo CD30XCD16A con un anticuerpo antagonista anti-PD-1 para terapia
EP3156417A1 (en) 2015-10-13 2017-04-19 Affimed GmbH Multivalent fv antibodies
CN105367660B (zh) * 2015-12-22 2018-12-21 深圳市北科生物科技有限公司 一种抗cd16a抗原和抗muc1抗原的双特异性抗体
IL276903B2 (en) * 2018-03-14 2025-12-01 Affimed Gmbh Bispecific egfr/cd16 antigen-binding protein

Similar Documents

Publication Publication Date Title
JP2021515798A5 (https=)
IL276903B1 (en) Bispecific egfr/cd16 antigen-binding protein
JP2021042257A5 (https=)
JP2021503455A5 (https=)
JP2020180158A5 (https=)
JP2020063262A5 (https=)
JP2020114210A5 (https=)
JP2017504578A5 (https=)
JP2020533311A5 (ja) NKG2D、CD16およびNectin4に結合するタンパク質
JP2013515508A5 (https=)
JPWO2019137548A5 (https=)
JPWO2019129221A5 (https=)
JP2010502183A5 (https=)
JPWO2019175368A5 (https=)
KR20200013230A (ko) 적어도 cd3 및 hsa를 표적화하는 헤테로-이량체 다중 특이적 항체 포맷
JP2024113040A5 (https=)
JP2025160226A5 (https=)
JP2021512604A5 (https=)
JPWO2022042488A5 (https=)
JPWO2021064137A5 (https=)
CN114786720A (zh) TriAx抗体的组合物及其制备和使用方法
JPWO2022111425A5 (https=)
JPWO2021030680A5 (https=)
JPWO2022268192A5 (https=)
JPWO2020073131A5 (https=)